Clinical trial · Interventional
The Science of the Art of Palliative Care
The Science of the Art of Palliative Care Pilot
NCT05137782CI-TRIAL-00073384completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Specialty Palliative Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Arm 1
- description
- Patients and care partners receive specialty primary care and participate in pre- and post- functional MRI scans to measure the effects of the specialty palliative care intervention.
- interventionNames
- Other: Specialty Palliative Care
Primary outcomes (1)
- measure
- Operationalization as measured by the creation of a manual of operating procedures and web-based data collection forms
- timeFrame
- 6 months
- description
- Establish acceptable operating procedures and data collection instruments which can be replicated for future projects.
Secondary outcomes (9)
- measure
- Feasibility as measured by participant interest
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or older * Patient: has received a diagnosis of advanced lung or gastrointestinal cancer within the last 24 weeks (note: advanced GI cancer will likely be pancreatic or colorectal) * Care partner: care partner of a patient who has received a diagnosis of metastatic lung or gastrointestinal cancer who has provided consent for study (either with our without functional MRI study visits) * Be able to understand study requirements and make an informed decision to participate * Be able to speak and read English Exclusion Criteria: * Life expectancy of \<8 weeks * Known brain metastases * Claustrophobia * Both patient and care partner refuse to participate in fMRI scan (ie., either patient or care partner must agree to an fMRI scan in order for either to participate) * Contraindications to MRI (e.g.: implanted or embedded metal/metal fragments. Metals in the body make the participant unable to undergo an MRI which makes them ineligible for study participation).
References
Publications (1)
- DERIVEDFanouraki E, Knotts JD, Page CA, Perry A, Wager TD, Wheatley TP, Ahern C, Barnato AE. Neural Correlates of Palliative Care: A Feasibility Trial in Patients with Metastatic Gastrointestinal and Lung Cancer. Res Sq [Preprint]. 2026 May 11:rs.3.rs-9215484. doi: 10.21203/rs.3.rs-9215484/v1. PMID 42183384